tailieunhanh - Mutational status of synchronous and metachronous tumor samples in patients with metastatic non-small-cell lung cancer

Despite reported discordance between the mutational status of primary lung cancers and their metastases, metastatic sites are rarely biopsied and targeted therapy is guided by genetic biomarkers detected in the primary tumor. This situation is mostly explained by the apparent stability of EGFR-activating mutations. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN